Limit this search to....

Gene Therapy for Autoimmune and Inflammatory Diseases 2010 Edition
Contributor(s): Chernajovsky, Yuti (Editor), Robbins, Paul D. (Editor)
ISBN: 3034601646     ISBN-13: 9783034601641
Publisher: Springer
OUR PRICE:   $208.99  
Product Type: Hardcover - Other Formats
Published: May 2010
Qty:
Temporarily out of stock - Will ship within 2 to 5 weeks
Additional Information
BISAC Categories:
- Medical | Immunology
- Medical | Genetics
- Medical | Biochemistry
Dewey: 611.018
Series: Milestones in Drug Therapy
Physical Information: 0.8" H x 6.5" W x 9.1" (1.60 lbs) 239 pages
 
Descriptions, Reviews, Etc.
Publisher Description:
In this monograph about gene therapy of autoimmune and inflammatory d- orders we have gathered international experts and leaders from different fields to review the state of the art advances on topics ranging from disease entities to vectors and engineered cells. The different approaches described in each chapter take into consideration the biomedical knowledge of these diseases and address the complexities of delivering long-term genetic interventions. Gene therapy also serves as a testing ground for new therapeutic entities and helps provide proof of principle for their potential therapeutic role in animal models of disease. Scaling up from mice to men still remains an important h- dle not only from the quantitative point of view, but also for currently unknown and unexpected secondary effects of the vector or the transgene. Some of these approaches have already been tested in the clinic, but much more needs to be done to understand the human conditions treated and the n- ural history of their pathology. We are indebted to the secretarial assistance of Ms. Lin Wells (Bone and Joint Research Unit, London, UK) and the help of Hans Detlef Kl ber for his help in getting this book published. We hope this book will be of interest to c- nicians and scientists and inspiring to students of the subject who will use their own ingenuity and knowledge to further forward this discipline into clinical use.